51
Quality Score
Solid
Medinfo: Medical information
✍️ bumetric analysis
“
Medinfo: Medical information is an Android app from Roshetta Info in the Medical category, currently rated 3.4★ across 2,830 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 51: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Revenue · today and ahead
Today
$5.0K/mo
In 12 months
$5.2K – $10.8K
In 24 months
$6.4K – $19.2K
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 48/100MID TIERunderperforming peersRevenue Strength
3.7
Product Quality
6.0
Market Position
0.0
Growth Velocity
5.0
Defensibility
6.8
Operational Safety
8.0
Founder Strength
3.8
Monetization Maturity
5.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 3.35★ across 2,830 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
🧪
Tech & Domain Intel — facebook.com
- Tech stack
- Google Workspace · Meta (Facebook) Ads
Derived from public RDAP + DNS TXT records (no scraping, no login).
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Low install base (2,830 ratings)METRIC | +$1,500 | |
| Below-average rating (3.4★)METRIC | −$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
App Specs
🔐 Own this app? Claim & verify MRR →🔖 vVaries with device📂 Medical💰 Free📺 Ad-supported💎 IAP $6.49 - $23.99 per item🚀 Launched 2016 (9y old)
📝 About this app
هذا التطبيق يعطيك معلومات طبية عن الامراض وبروتوكولات العلاج و لا يتم بيع او شراء اي ادوية من خلاله.
التطبيق موجه للسادة الاطباء وهو يساعدهم في الحصول على معلومات مثل مكونات الدواء واستخداماته والجرعة والاثار الجانبية للمادة الفعالة.
لا يمكن شراء اي ادوية من التطبيق، التطبيق هو مجرد مساعد معلوماتي ولا يمكنك شراء او بيع الدواء من خلاله اطلاقا.
المعلومات الواردة بالتطبيق هي معلومات استرشادية توعوية وغير اساسية ويتم استخدامها على مسؤولية الطبيب.
------
- يحتوي على اكثر من 340 مرض وجميع المعلومات الخاصة به (العلاج - التشخيص - الاعراض ...الخ)… View full description on the official store →
التطبيق موجه للسادة الاطباء وهو يساعدهم في الحصول على معلومات مثل مكونات الدواء واستخداماته والجرعة والاثار الجانبية للمادة الفعالة.
لا يمكن شراء اي ادوية من التطبيق، التطبيق هو مجرد مساعد معلوماتي ولا يمكنك شراء او بيع الدواء من خلاله اطلاقا.
المعلومات الواردة بالتطبيق هي معلومات استرشادية توعوية وغير اساسية ويتم استخدامها على مسؤولية الطبيب.
------
- يحتوي على اكثر من 340 مرض وجميع المعلومات الخاصة به (العلاج - التشخيص - الاعراض ...الخ)… View full description on the official store →
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Medinfo: Medical information
- Developer
- Roshetta Info
- Bundle ID
- com.RoshettaMobile.roshetta
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.facebook.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $595/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $6.49 - $23.99 per item
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth2,830 ratings+28% lifetimeShow 3-year history estimate ▾
Tracked (1 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
Full revenue analysis
Read the article-style breakdown for Medinfo: Medical information: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.